Role of farnesoid X receptor and bile acids in alcoholic liver disease

被引:1
|
作者
Sharon Manley [1 ]
Wenxing Ding [1 ]
机构
[1] Department of Pharmacology, Toxicology and Therapeutics, the University of Kansas Medical Center
基金
美国国家卫生研究院;
关键词
Farnesoid X receptor; Bile acids; Autophagy; Alcoholic liver disease; FoxO3;
D O I
暂无
中图分类号
R96 [药理学];
学科分类号
100602 ; 100706 ;
摘要
Alcoholic liver disease(ALD) is one of the major causes of liver morbidity and mortality worldwide. Chronic alcohol consumption leads to development of liver pathogenesis encompassing steatosis, inflammation, fibrosis, cirrhosis, and in extreme cases, hepatocellular carcinoma. Moreover,ALD may also associate with cholestasis. Emerging evidence now suggests that farnesoid X receptor(FXR) and bile acids also play important roles in ALD. In this review, we discuss the effects of alcohol consumption on FXR, bile acids and gut microbiome as well as their impacts on ALD. Moreover, we summarize the findings on FXR, Fox O3a(forkhead box-containing protein class O3a) and PPARα(peroxisome proliferator-activated receptor alpha) in regulation of autophagy-related gene transcription program and liver injury in response to alcohol exposure.
引用
收藏
页码:158 / 167
页数:10
相关论文
共 50 条
  • [41] The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
    Sun, Lulu
    Cai, Jie
    Gonzalez, Frank J.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2021, 18 (05) : 335 - 347
  • [42] The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
    Lulu Sun
    Jie Cai
    Frank J. Gonzalez
    Nature Reviews Gastroenterology & Hepatology, 2021, 18 : 335 - 347
  • [43] On the Evolution of Bile Salts and the Farnesoid X Receptor in Vertebrates
    Frisch, Kim
    Alstrup, Aage Kristian Olsen
    PHYSIOLOGICAL AND BIOCHEMICAL ZOOLOGY, 2018, 91 (02): : 797 - 813
  • [44] β-Defensin 1 ls Prominent in the Liver and Induced During Cholestasis by Bilirubin and Bile Acids via Farnesoid X Receptor and Constitutive Androstane Receptor
    Klag, Thomas
    Thomas, Maria
    Ehmann, Dirk
    Courth, Lioba
    Mailaender-Sanchez, Daniela
    Weiss, Thomas S.
    Dayoub, Rania
    Abshagen, Kerstin
    Vollmar, Brigitte
    Thasler, Wolfgang E.
    Stange, Eduard F.
    Berg, Christoph P.
    Malek, Nisar P.
    Zanger, Ulrich M.
    Wehkamp, Jan
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [45] Liver X receptor and farnesoid X receptor as therapeutic targets
    Rader, Daniel J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (11): : 15N - 19N
  • [46] Hepatoprotective effect of Typhaneoside on non-alcoholic fatty liver disease via farnesoid X receptor in vivo and in vitro
    Zheng, Yi
    Zhao, Jian
    Miao, Deyu
    Xu, Tingting
    Wang, Liziniu
    Liu, Changhui
    Gao, Yong
    Yu, Lili
    Shen, Chuangpeng
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 164
  • [47] AKR1B7 Is Induced by the Farnesoid X Receptor and Metabolizes Bile Acids
    Schmidt, Daniel R.
    Schmidt, Samuel
    Holmstrom, Sam R.
    Makishima, Makoto
    Yu, Ruth T.
    Cummins, Carolyn L.
    Mangelsdorf, David J.
    Kliewer, Steven A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (04) : 2425 - 2432
  • [48] Bile acids and sphingolipids in non-alcoholic fatty liver disease
    Jackson Kaitlyn G.
    Way Grayson W.
    Zhou Huiping
    中华医学杂志英文版, 2022, 135 (10) : 1163 - 1171
  • [49] Bile acids and sphingolipids in non-alcoholic fatty liver disease
    Jackson, Kaitlyn G.
    Way, Grayson W.
    Zhou, Huiping
    CHINESE MEDICAL JOURNAL, 2022, 135 (10) : 1163 - 1171
  • [50] Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis
    Orlando, R.
    Azzalini, L.
    Orando, S.
    Lirussi, F.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):